jens juul holst glp 1 Holst: physician-scientist and co-discoverer of GLP-1 🎉 Congratulations to Professor Jens

Injectable vs oral is another decision point

Science Says As body weight decreases, the likelihood of developing a chronic illness drops significantly with one report seeing significantly fewer cases of kidney failure and cardiovascular disease for people with type 2 diabetes

E., Abualigah, L., Abuhaija, B

The FDA-mandated Boxed Warning for Zepbound states that tirzepatide causes thyroid C-cell tumors in rodents and that it is unknown whether Zepbound causes thyroid C-cell tumors, including MTC, in humans

Because GLP-1 drugs are expensive, can be difficult to access, and have significant side effects, many people have sought to increase their production of the natural hormone via nutritional modifications